Erratum: Effect of a novel botanical agent Drynol Cibotin on human osteoblast cells and implications for osteoporosis: Promotion of cell growth, calcium uptake and collagen production (Phytotherapy Research (2010) 24, Supplement 2 DOI: 10.1002/ptr.3026);Effect of a novel botanical agent drynol cibotin on human osteoblast cells and implications for osteoporosis: Promotion of cell growth, calcium uptake and collagen production

Phytotherapy Research

Volumn 24, Issue SUPPL. 2, 2010, Pages

  Wegiel, Barbara ^a   Persson, Jenny L ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Bone; Calcium; Collagen; Drynol cibotin; Osteoporosis

Indexed keywords

AMINO ACID; ARGININE; CALCITRIOL; CALCIUM; COLLAGEN; COLLAGEN TYPE 1; DRYNOL CIBOTIN; LAMININ; LYSINE; PHYTOMENADIONE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VITAMIN; HERBACEOUS AGENT; LAMININ BETA2;

ANGELICA SINENSIS; APOPTOSIS; ARTICLE; ASTRAGALUS MEMBRANACEUS; CALCIUM TRANSPORT; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SPREADING; CHINESE MEDICINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; CUSCUTA; DRUG EFFECT; DRYNARIA FORTUNE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIGUSTRUM; MEDICINAL PLANT; NICK END LABELING; OSTEOBLAST; OSTEOPOROSIS; PROTEIN SYNTHESIS; PSORALEA; SOYBEAN; TRADITIONAL MEDICINE; WESTERN BLOTTING; YAM; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; METABOLISM;

ANGELICA SINENSIS; ASTRAGALUS MEMBRANACEUS; CUSCUTA CHINENSIS; DIOSCOREA VILLOSA; DRYNARIA; GLYCINE MAX; LIGUSTRUM LUCIDUM;

APOPTOSIS; CALCIUM; CELL LINE; CELL PROLIFERATION; COLLAGEN TYPE I; DRUGS, CHINESE HERBAL; HUMANS; LAMININ; OSTEOBLASTS; OSTEOPOROSIS;

EID: 77953888794     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3253     Document Type: Erratum

References (41)

1. Berridge MJ, Bootman MD, Roderick HL. 2003. Calcium Signalling: Dinamics, homeostasis and remodelling. Mol Cell Biol 14: 517-525.
2. Benksy D, Gamble A, Kaptchuk T. 1993. Chinese Herbal Medicine: Materia Medica. Eastland Press: Seattle, USA.
3. Cotter A, Cashman KD. 2003. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 61(10): 346-351. (Pubitemid 37243713)
4. Gueguen L, Pointillart A. 2000. The bioavailability of dietary calcium. J Am Coll Nutr 19(2): 119S-136S.
5. Harada SI, Rodan GI. 2003. Control of osteoblast function and regulation of bone mass. Nature 423: 349-355. (Pubitemid 40852710)
6. Harris SA, Enger RJ, Riggs BL, Spelsberg TC. 1995. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10(2): 178-186.
7. Heaney RP. 2003. How does bone support calcium homeostasis? Bone 33(3): 264-268.
8. Iwamoto J, Yeh JK, Takeda T, Ichimura S, Sato Y. 2003. Comparative effects of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats. Bone 33(4): 557-566. (Pubitemid 37222382)
9. Jeong JC, Kang SK, Youn CH, Jeong CW, Kim HM, Lee YC, Chang YC, Kim CH. 2003. Inhibition of Drynariae Rhizoma extracts on bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts. Int Immunopharmacol 3(12): 1685-1697.
10. Kang HJ, Ansbacher R, Hammoud MM. 2002. Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 79(3): 195-207. (Pubitemid 35365772)
11. Kim C, Ha H, Lee JH, Kim JS, Song K, Park SW. 2003. Herbal extract prevents bone loss in ovariectomized rats. Arch Pharm Res 26(11): 917-924.
12. Lim SH, Ha TY, Kim SR, Ahn J, Park HJ, Kim S. 2008. Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats. Br J Nutr 19: 1-9 [Epub ahead of print]
13. Lin CY, Sun JS, Sheu SY, Lin FH, Wang YJ, Chen LT. 2002 The effect of Chinese medicine on bone cell activities. Am J Chin Med 30(2-3): 271-285.
14. Mackie EJ. 2003. Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 35(9): 1301-1305.
15. Miura H, Nishida H, Linuma M. 1996. Effect of crude fractions of psoralea corylifolia seed extract on bone calcification. Planta Med 62(2): 150-153. (Pubitemid 26163220)
16. Mizuno M, Fujisawa R, Kuboki Y. 2000. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2 beta1 integrin interaction. J Cell Physiol 184(2): 207-213. (Pubitemid 30432312)
17. Morales O, Samuelsson MK, Lindgren U, Haldosen LA. 2004. Effects of 1alpha, 25-dihydroxyvitamin D3 and growth hormone on apoptosis and proliferation in UMR 106 osteoblast-like cells. Endocrinology 145(1): 87-94. (Pubitemid 38094504)
18. Raiche AT, Puleo DA. 2004. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 25: 677-685.
19. Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. 2003. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem 89(3): 633-646. (Pubitemid 36648784)
20. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone disease. Science 289: 1508-1514.
21. Shiels MJ, Mastro AM, Gay CV. 2002. The effect of donor age on the sensitivity of osteoblasts to the proliferative effects of TGF (beta) and 1, 25 (OH (2)) vitamin D (3). Life Sci 70(25): 2967-2975.
22. Schaafsma A, de Vries PJ, Saris WH. 2001. Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr 41(4): 225-249. (Pubitemid 33755816)
23. Seeman E. 2003. Invited review: Pathogenesis of osteoporosis. J Appl Physiol 95: 2142-2151.
24. Setchell KD, Lydeking-Olsen E. 2003. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78(3): 593S-609S. (Pubitemid 40012554)
25. Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Hamel C, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G. 2003. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev 4: CD004526.
26. Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. 2002. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 23(4): 552-559.
27. Suh KS, Koh G, Park CY, Woo JT, Kim SW, Kim JW, Park IK, Kim YS. 2003. Soybean isoflavones inhibit tumor necrosis factor-alpha-induced apoptosis and the production of interleukin-6 and prostaglandin E2 in osteoblastic cells. Phytochemistry 63(2): 209-215. (Pubitemid 36560140)
28. Sun JS, Lin CY, Dong GC, Sheu SY, Lin FH, Chen LT, Wang YJ. 2002. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials 23(16): 3377-3385.
29. Taira M, Nakao H, Takahashi J, Araki Y. 2003. Effects of two vitamins, two growth factors and dexamethasone on the proliferation of rat bone marrow stromal cells and osteoblastic MC3T3-E1 cells. J Oral Rehabilitation 30: 697-701. (Pubitemid 37260150)
30. Thiebaud D, Guenther HL, Porret A, Burckhardt P, Fleisch H, Hofstetter W. 1994. Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines. J Bone Miner Res 9(9): 1347-1354. (Pubitemid 24268845)
31. Torricelli P, Fini M, Giavaresi G, Giardino R, Gnudi S, Nicolini A, Carpi A. 2002. L-Arginine and L-Lysine stimulation on cultured human osteoblasts. Biomed Pharmacother 56(10): 492-497. (Pubitemid 36013460)
32. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA. 2001. Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 11(1-3): 199-226.
33. Wang XL, Wang NL, Zhang Y, Gao H, Pang WY, Wong MS, Zhang G, Qin L, Yao XS. 2008. Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (KUNZE) J. SM. on osteoblastic proliferation using an osteoblast-like cell line. Chem Pharm Bull (Tokyo) 56(1): 46-51.
34. Wang D, Li F, Jiang Z. 2001 Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med 67(8): 748-749. (Pubitemid 33044484)
35. Yang Q, Populo SM, Zhang J, Yang G, Kodama H. 2002. Effect of Angelica sinensis on the proliferation of human bone cells. Clin Chim Acta 324(1-2): 89-97. (Pubitemid 35245499)
36. Yao CH, Tsai HM, Chen YS, Liu BS. 2005. Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chinese medicine as a bone substitute. J Biomed Mater Res B Appl Biomater 75(2): 277-288.
37. Yen ML, Su JL, Chien CL, Tseng KW, Yang CY, Chen WF, Chang CC, Kuo ML. 2005. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol 68(4): 1061-1073.
38. Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS. 2006. Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29(2): 291-296. (Pubitemid 43200899)
39. Zittermann A. 2001. Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care 4(6): 483-487. (Pubitemid 34755403)
40. Sassa S, Kikuchi T, Shinoda H, Suzuki S, Kudo H, Sakamoto S. 2003. Preventive effect of ferulic acid on bone loss in ovariectomized rats. In Vivo 17(3): 277-280. (Pubitemid 36958119)
41. Xiong Z, Wang D, Xu Y, Li F. 2003. Osteoblastic differentiation bioassay and its application to investigating the activity of fractions and compounds from Psoralea corylifolia L. Pharmazie 58(12): 925-928. (Pubitemid 37541643)